Articles On Avita Medical (ASX:AVH)

Regenerative medicine company AVITA Medical (ASX:AVH) has announced topline results from its pivotal trial evaluating the safety and effectiveness of the RECELL System combined with meshed autograft for reduction of donor skin harve...

By Greg Peel Just a Scare Wall Street had shot up initially on a lower PPI print on Thursday night before rolling over to close flat, suggesting maybe the comeback rally had run its course. The local market thus ran scared from the open, dr...

The benchmark grumbles to a slovenly 0.7% slide Aussie bond yields have risen 13 basis points as recession chatter continues Domino’s sinks after getting laughed out of Italy The ASX has been consistently indolent, even – dare we say it –...

The share market secured its longest weekly winning streak in more than a year after weathering profit-taking today after Wall Street’s “peak-inflation” relief rally ran out of gas. The S&P/ASX 200 eked out a fourth week of gains. A...

The share market came close to erasing its gains for the week following soft leads from Wall Street and a bout of profit-taking at two-month highs. The S&P/ASX 200 remained on track for a fourth week of gains despite falling 42 point...

Avita Medical’s top line results on RECELL disappoint investors Cynata has completed a strategic review, and will terminate its Covid-19 study Resmed’s revenue grows in FY22 Shares in regenerative cells biotech Avita Medical (ASX:AVH) plu...

The AVITA Medical Inc (ASX: AVH) share price is falling on the back of the company’s financial results. The medical technology company’s share price is currently $1.895, a 16.5% fall. For perspective, the S&P/ASX 200 Index (ASX...

AVITA Medical (AVH) reports positive top line results for its RECELL trial in patients with soft-tissue injuries The company released results from its randomised, controlled trial which evaluated the effectiveness of the RECELL system when...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX 200 will open lower on Friday Wall Street fades away late in the trading day Bitcoin has rallied further Local shares are set to open lower today. At 8am AEST, the ASX 200 August futures contract is pointing down by 0.35%. Overnig...

Aussie stocks were set to open sharply higher after inflation slowed more than expected in the US, easing pressure on the Federal Reserve to raise rates aggressively. A relief rally lifted two of Wall Street’s three main indices by more...

Aussie stocks were poised for a cautious start to the week following a mixed close in the US after blowout jobs figures dashed hopes of a slowdown in interest rate hikes.   Surging bond yields helped drive the S&P 500 and Nasdaq Comp...

The ASX 200 is down, the XEC surged late, up 1.5%  Tech stocks rise, Cons discretionary and energy dragging US Futures flat, Chinese markets higher on Pelosi goes to Taipei day   Ahead of the close here in Sydney, US Futures connected to...

The Polynovo Ltd (ASX: PNV) share price is trading in the green during the afternoon session on Wednesday. At the time of writing, shares in the medical devices company are trading 6.33% higher at $1.68 apiece. Earlier this afternoon, t...

The AVITA Medical Inc (ASX: AVH) share price has shot well into the green in lunchtime trade on Wednesday. At the time of writing, the company’s shares are 19.88% higher at $2.05 apiece on no news. In broader market moves, the S&P...

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated. This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated. What happened Nasdaq I...

The Metalstech Ltd (ASX: MTC) share price is lifting into the green in early trade on Wednesday. At the time of writing, the gold and lithium explorer is trading around 11% higher at 40.5 cents apiece following the release of a company a...

The ASX Ltd (ASX: ASX) share price is in the red. Its tumble comes after the market operator announced that its long-awaited CHESS replacement likely won’t be operational until at least 2024. The company has also commissioned an independe...

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated. This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated. What happened Shares o...

What are the risks of investing in biotechs? How to value a biotech Top 10 crucial trials coming up for ASX biotechs in 2022 Risks of investing in biotechs Historical data shows that biotech is one the best sectors to put your money in ov...

This month I’ve been looking at a number of shares that Bell Potter has rated as its top picks for FY 2023. You can read about its tech picks here and its energy picks here. On this occasion, let’s take a look at a couple of ASX health...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Morningstar bullish on ability of ASX healthcare sector to come back S&P ASX 200 Health Care Index outperformed S&P ASX 200 by more than 8% in Q3FY22 Morningstar picks Avita Medical and Sigma Healthcare as two standouts Morningst...

Avita Medical makes spray on skin for burns and soft tissue injuries HITIQ’s concussion tech is popular for athletes and sports teams PainChek’s smartphone app can tell if babies or older Aussies are in pain There’s a plethora of biotech...

Regenerative medicine company AVITA Medical (ASX:AVH) has won the Australasian Investor Relations Association Award for Best Investor Relations by a company in the S&P/ASX Emerging Companies Index.

Avita Medical (AVH) reports a 14 per cent year-on-year decrease in net revenue to $7.5 million in the March quarter Despite this, commercial sales rose 61 per cent to $7.4 million, reflecting sales of its RECELL system which treats acute t...

The Avita Medical Inc (ASX: AVH) share price is down 7.2% to $1.62 in early trade. Avita focuses on regenerative medicines. Its spray-on Recell medicine is used to treat burn patients. Below we look at the ASX healthcare share’s first-quar...

The deep sell down of the US biotech sector has resulted in the valuation of many of the ASX-listed life science plays looking a tad sickly, too. Arguably, many of them were overvalued in the first place. But in many cases the companies ar...

Plenty of ASX healthcare shares fell to 52-week lows today. The industry has not been immune to the ASX share market selloff. There is ongoing volatility with investors keeping an on the Russian conflict with Ukraine, the sanctions and the...

As well as being home to countless blue chip shares, the Australian share market is home to a good number of promising small caps. Three small cap shares that could be worth adding to your watchlist are listed below. Here’s what you need t...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX 200 Health Index (XHJ) is trading lower by 0.30% at the time of writing, compared to the broader index which is up by 0.90%. Regenerative medicine company, Avita Medical (ASX:AVH), has been awarded a purchasing contract from Premier...

The ASX Emerging Companies index (XEC) ran free on Tuesday, climbing over 3%, apparently unrestrained by the various macro or geopolitical issues bothering the rest of us. That said, the more gown up ASX200 also lifted on Tuesday, gaining a...

Skin regeneration specialist Avita Medical (AVH) bolsters revenue and shrinks its net loss for the six months to the end of December 2021 The company says over this time period, it grew revenue by 37 per cent to US$14 million (A$19 million...

The Avita Medical Inc (ASX: AVH) share price is skyrocketing today after the company released its financial results for a six month “transition period” ended 31 December 2021. The company announced in December 2021 that it wanted to change...

The ASX 200 Health Index (XHJ) is trading higher by 0.55% at the time of writing, compared to the broader index which is up by 0.45%. Cannabis stock Avecho Biotechnology (ASX:AVE) announced today that patient dosing has commenced for its Ph...

Cathie Wood’s ARK Genomic Revolution ETF (BATS: ARKG) and ASX-listed biotech stocks have been beaten up mercilessly for a year. The ETF peaked at US$112.23 on the 8th of February 2021, and is down 60% to US$45.99.   Source: Yahoo FinanceHea...

ShareCafeBuying Opportunities Beckon Amid Biotech Bloodbath The sharp retreat in global biotech valuations is creating rare buying opportunities as investors flee ‘riskier’ sectors on the back of rising interest rates, dwindling liquidity a...

In this week’s video insight Joseph discusses the key drivers of The Montgomery Fund’s performance for calendar year 2021. Overall, 2021 was a successful year for The Montgomery Fund. The total return of 25.1 per cent after fees represented...

Regenerative medicine company AVITA Medical (ASX:AVH) has completed enrollment in its pivotal trial for the use of the RECELL System for soft tissue reconstruction.

The Montgomery Fund (The Fund) closed an impressive 2021, outperforming the S&P/ASX 300 Accumulation Index by 7.61 per cent, after fees. Over the year The Fund also paid a solid distribution at 30 June and a smaller one at 31 December,...

The AVITA Medical Inc (ASX: AVH) share price is pushing higher on Tuesday morning. In morning trade, the regenerative medicine company’s shares are up 3.5% to $3.25. Why is the AVITA share price pushing higher? Investors have been bidding...

AVITA Medical Inc. (AVH) releases preliminary unaudited estimates of its top line results for its latest financial quarter AVITA’s total revenue increased 35 per cent to US$6.9 million, compared to US$5.1 million over the same quarter last...

Selling pressure eases on Wall Street After the big tumble on Wednesday following the release of Fed’s rate cut plans, US stocks fell more modestly overnight. All three major benchmarks were down – the S&P 500 by 0.10%, the Dow by 0.47%...

AVITA Medical (AVH) reports its preclinical data establishes proof of concept in two key areas of cell-based gene therapy – skin rejuvenation and epidermolysis bullosa Data shows successful regeneration of the skin when AVITA’s Spray-On Sk...

The life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, the share prices of major vaccine-producing companies have surged astronomically as COVID-19  ravaged the world. Nasdaq-listed BioNTech, which...

The AVITA Medical Inc (ASX: AVH) share price has dropped to a 52-week low today despite news that the medical producer has entered its RECELL System product into a trial. Today’s slide comes off the back of a 2.78% fall yesterday after th...

Shares in regenerative medicine group Avita Medical Inc (ASX: AVH) are in the red today, down 2.78% to $3.50. This means the Avita share price is now down 22.08% over the past month. Today’s falling share price comes amid an announcement...

Trading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers and other famous investors over the last fortnight. Specifically, Stockhead tracks substantial shareholder movements, being shareholders hold...

It’s now been two-and-a-half years since US tech stock Life360 (ASX:360) listed on the ASX at $4.79 a share and it now sits at $13.51. The company’s flagship product is a smartphone app that provides information such as where families membe...